Problems of Settling Intellectual Property Bankruptcy Estate
- DOI
- 10.2991/978-2-38476-218-7_77How to use a DOI?
- Keywords
- — Bankruptcy; Intellectual Property Rights; Problems
- Abstract
The primary objective of this study is to analyze and formulate the problems of resolving bankruptcy assets for intellectual property rights. This research employs a doctrinal or normative legal research with a statutory and conceptual approach. This research utilizes primary and secondary legal materials, employing qualitative analysis. This research states that intellectual property rights are an intangible object that has economic value (intangible asset), so it is appropriate to use intellectual property rights as bankruptcy assets to pay off debtors’ debts. Problems occur when the curator settles the bankruptcy estate of intellectual property rights and experiences difficulties in appraisal, because there are no statutory regulations that govern the value of intellectual property rights, resulting in a legal vacuum and the need for a special institution regarding the valuation of intellectual property rights.
- Copyright
- © 2024 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Erlan Nopri AU - Hartiwiningsih Hartiwiningsih AU - Budi Agus Riswandi PY - 2024 DA - 2024/02/22 TI - Problems of Settling Intellectual Property Bankruptcy Estate BT - Proceedings of the International Conference On Law, Economic & Good Governance (IC-LAW 2023) PB - Atlantis Press SP - 462 EP - 466 SN - 2352-5398 UR - https://doi.org/10.2991/978-2-38476-218-7_77 DO - 10.2991/978-2-38476-218-7_77 ID - Nopri2024 ER -